title: [Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on adrenal insufficiency and osteoporosis].
abstract: In the attempt to harmonize clinical practices between different French transplantation centers, the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) set up the third annual series of workshops which brought together practitioners from all member centers and took place in October 2012 in Lille. Here we report our results and recommendations regarding the management of short and long-term endocrine dysfunction following allogeneic stem cell transplantation. The key aim of this workshop was to give an overview on secondary adrenal insufficiency and osteoporosis post-transplant.
authors.affiliation: Service d'hématologie adulte, institut de cancérologie de la Loire, 108 bis, avenue Albert-Raimond, Saint-Priest-en-Jarez, France.
authors.forename: J
authors.initials: J
authors.lastname: Cornillon
authors.forename: M-C
authors.initials: MC
authors.lastname: Vantyghem
authors.forename: M A
authors.initials: MA
authors.lastname: Couturier
authors.forename: E
authors.initials: E
authors.lastname: de Berranger
authors.forename: S
authors.initials: S
authors.lastname: François
authors.forename: E
authors.initials: E
authors.lastname: Hermete
authors.forename: N
authors.initials: N
authors.lastname: Maillard
authors.forename: A
authors.initials: A
authors.lastname: Marcais
authors.forename: R
authors.initials: R
authors.lastname: Tabrizi
authors.forename: C
authors.initials: C
authors.lastname: Decanter
authors.forename: R
authors.initials: R
authors.lastname: Duléry
authors.forename: F
authors.initials: F
authors.lastname: Bauters
authors.forename: I
authors.initials: I
authors.lastname: Yakoub-Agha
mesh_terms: D000309:Adrenal Insufficiency / Q000209:etiology / Q000628:therapy*; D000328:Adult; D015519:Bone Density; D002648:Child; D019587:Dietary Supplements; D004164:Diphosphonates / Q000627:therapeutic use; D004700:Endocrine System Diseases / Q000209:etiology* / Q000628:therapy*; D005938:Glucocorticoids / Q000009:adverse effects; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D010024:Osteoporosis / Q000209:etiology / Q000628:therapy*; D014184:Transplantation, Homologous; D014815:Vitamins / Q000627:therapeutic use
chemical_list: D004164:Diphosphonates; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D014815:Vitamins
keywords: Allogeneic stem cell transplantation; Allogreffe de cellules souches hématopoïétiques; Corticothérapie; Glucocorticoid treatment; Guidelines; Insuffisance corticotrope; Metabolic dysfunction; Osteoporosis; Ostéoporose; Secondary adrenal insufficiency; Troubles métaboliques